Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harm van Tinteren

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Translational Lung Cancer Research|July 25, 2015
Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?Berend J Slotman, Harm van Tinteren
Nature Clinical Practice. Oncology|June 8, 2006
Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?Barbara G Taal, Annemieke Cats, Harm van Tinteren
Journal of Surgical Oncology|April 6, 2011
Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experienceDaphne Hompes, Henk Boot, Harm van Tinteren, et al.
Annals of Surgical Oncology|March 10, 2018
Centralization of Upper Gastrointestinal Cancer Care Should be Dictated by Quality of CareWouter Te Riele, Harm van Tinteren, Johanna van Sandick
The Laryngoscope|April 5, 2005
Sleep endoscopy versus modified Mallampati score in sleep apnea and snoringCindy den Herder, Harm van Tinteren, Nico de Vries
The Laryngoscope|April 5, 2005
Hyoidthyroidpexia: a surgical treatment for sleep apnea syndromeCindy den Herder, Harm van Tinteren, Nico de Vries
PET Clinics|May 10, 2016
Evaluation of Cost-effectiveness of FDG-PET in Non-Small Cell Lung CancerOtto S Hoekstra, Harm van Tinteren, Egbert F Smit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
FDG-PET in addition to conventional work-up in non-small-cell lung cancerHarm van Tinteren, Egbert F Smit, Otto S Hoekstra
Archives of Disease in Childhood|March 8, 2016
Evidence for a delay in diagnosis of Wilms' tumour in the UK compared with Germany: implications for primary care for childrenKathy Pritchard-Jones, Norbert Graf, Harm van Tinteren, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and studyIngrid Ora, Harm van Tinteren, Christophe Bergeron, et al.
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Translational Lung Cancer Research|July 25, 2015
Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?Berend J Slotman, Harm van Tinteren
Nature Clinical Practice. Oncology|June 8, 2006
Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?Barbara G Taal, Annemieke Cats, Harm van Tinteren
Journal of Surgical Oncology|April 6, 2011
Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experienceDaphne Hompes, Henk Boot, Harm van Tinteren, et al.
Annals of Surgical Oncology|March 10, 2018
Centralization of Upper Gastrointestinal Cancer Care Should be Dictated by Quality of CareWouter Te Riele, Harm van Tinteren, Johanna van Sandick
The Laryngoscope|April 5, 2005
Sleep endoscopy versus modified Mallampati score in sleep apnea and snoringCindy den Herder, Harm van Tinteren, Nico de Vries
The Laryngoscope|April 5, 2005
Hyoidthyroidpexia: a surgical treatment for sleep apnea syndromeCindy den Herder, Harm van Tinteren, Nico de Vries
PET Clinics|May 10, 2016
Evaluation of Cost-effectiveness of FDG-PET in Non-Small Cell Lung CancerOtto S Hoekstra, Harm van Tinteren, Egbert F Smit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
FDG-PET in addition to conventional work-up in non-small-cell lung cancerHarm van Tinteren, Egbert F Smit, Otto S Hoekstra
Archives of Disease in Childhood|March 8, 2016
Evidence for a delay in diagnosis of Wilms' tumour in the UK compared with Germany: implications for primary care for childrenKathy Pritchard-Jones, Norbert Graf, Harm van Tinteren, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and studyIngrid Ora, Harm van Tinteren, Christophe Bergeron, et al.
Pageof 22